RenovoRx Inc
RNXT
$1.57+1.29%
End of day · as of Sep 30, 2026, 3:25 AM ET
Mkt cap
$47.00M
EV/Sales
35.6
P/E ratio
N/A
FY2025 Revenue
$1.12M
EPS (TTM)
$-0.31
Gross Margin (FY2025)
70.88%
Profit Margin (FY2025)
-994.48%
Beta
1.32
Div yield
N/A
Sector
Healthcare
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported RNXT revenue for 2025-12-31 was $1.1M. Net income was -$11.2M. Revenue was up 2511.6% from 2024-12-31 to 2025-12-31. RNXT currently screens at market cap $47.0M.
Use this RNXT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RNXT income, balance, and cash tables.
RenovoRx Inc (RNXT) is a biotechnology company in the Healthcare sector.
Latest cached RenovoRx Inc (RNXT) revenue for Dec 31, 2025 was $1.1M. Net income was -$11.2M. Statements: https://lician.com/financials/rnxt
RenovoRx Inc (RNXT) market capitalization is $47.0M on the latest cached snapshot.
RenovoRx Inc (RNXT) cached previous close $1.55; day range $1.51 – $1.59; volume 369,076. Session quote: https://lician.com/quote/rnxt
RenovoRx Inc (RNXT) latest cached earnings event is "RNXT earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RNXT filing is 8-K · Jul 2, 2026. Filings: https://lician.com/sec/rnxt